The aptamer modification of EGFR (EGFRapt) can not only effectively increase the accumulation and tumor penetration ability of the RNA nanocarrier 4WJ in ESCC cells, but also significantly increase the distribution of carriers in mouse xenograft ESCC tissues. Here, EGFR is linked to esophageal squamous cell carcinoma.